US Broker Ratings

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 40% Potential Upside in the Biotech Arena

Investors with a keen interest in the biotechnology sector are increasingly setting their sights on Soleno Therapeutics, Inc. (NASDAQ: SLNO), an intriguing player focused on rare disease therapeutics. With a..

Verona Pharma plc (VRNA) Stock Analysis: Is This $7.84 Billion Biotech a Breath of Fresh Air for Investors?

Verona Pharma plc (NASDAQ: VRNA), a biopharmaceutical company rooted in the United Kingdom, stands at the forefront of innovation within the respiratory disease sector. With a market capitalization of $7.84..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 38.53% Upside Potential for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a veteran in the healthcare sector, is a prominent player in the medical devices industry. Founded in 1952 and headquartered in Hercules, California, the company..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Examining a 43% Upside Potential in Biotechnology

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), headquartered in West Conshohocken, Pennsylvania, is making waves in the biotechnology industry, a sector renowned for its high stakes and high rewards. Specializing in the..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 9.21% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, has become a focal point for investors seeking exposure to medical care facilities. With a market capitalization..

Corcept Therapeutics (CORT) Investor Outlook: Nearly 100% Upside Potential Awaits

Corcept Therapeutics Incorporated (NASDAQ: CORT), a dynamic player in the biotechnology sector, is capturing investor attention with its robust pipeline and impressive potential upside. With a market capitalization of $7.43..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 22% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, is making waves with its extensive range of home and alternate site infusion services across the United..

Integer Holdings Corporation (ITGR) Stock Analysis: Unlocking a 25.74% Upside Potential in Healthcare

Integer Holdings Corporation (NYSE: ITGR) has carved out a prominent position in the healthcare sector as a leading medical device contract development and manufacturing company. With its extensive portfolio that..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 27.81% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a significant player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $12.89 billion, the..

Prestige Consumer Healthcare (PBH) Investor Outlook: Navigating a Stable Growth Path with a 5.39% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is carving a niche in the competitive healthcare market with its expansive portfolio of over-the-counter (OTC) health and personal care products. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 49.7% Potential Upside in the Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, presents a compelling case for investors seeking opportunities in the healthcare industry. With its market capitalization standing at..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Precision Therapy Market with a 55.5% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, specializes in developing targeted therapies for genomically defined cancers and blood disorders. With a market capitalization of $8.27..

Repligen Corporation (RGEN) Stock Analysis: Unveiling a 43.70% Potential Upside in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its innovative solutions in the bioprocessing technology..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in Oncology with a 30.60% Revenue Surge

Exelixis, Inc. (NASDAQ: EXEL), a leading player in the biotechnology sector, is making waves with its robust focus on oncology. As a United States-based company, Exelixis is dedicated to the..

Oscar Health, Inc. (OSCR) Stock Analysis: Promising 33% Upside with Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) stands out in the healthcare sector, particularly in the healthcare plans industry, as a company with significant growth potential. With a current market capitalization of..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring the 70% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of savvy investors with its promising pipeline and a significant upside potential of 70.08%. This biopharmaceutical company, focused on developing therapies..

Legend Biotech Corporation (LEGN) Investor Outlook: A 107% Potential Upside Amidst Robust Revenue Growth

Legend Biotech Corporation (NASDAQ: LEGN), a pioneering entity in the field of biotechnology, has captured the attention of investors with its impressive revenue growth and promising product pipeline. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Uncovering a 43.72% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, offering a compelling investment opportunity with a significant potential upside of 43.72%. This clinical-stage biopharmaceutical company is headquartered in..

BioNTech SE (BNTX) Stock Analysis: Evaluating a 27.49% Potential Upside in the Biotech Arena

BioNTech SE (NASDAQ: BNTX) presents an intriguing investment opportunity for those with a keen interest in the biotechnology sector. Known for its groundbreaking work in immunotherapies targeting cancer and infectious..

Waystar Holding Corp. (WAY) Stock Analysis: 24% Potential Upside Beckons Investors

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its solid position in the healthcare sector, particularly in the health information services industry. As an innovative player..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds